Abstract：
BACKGROUND: To the best of our knowledge, there are no reporting guidelines for design, conduct and reporting of Finite Element studies in health sciences. We intend to propose specific and detailed guidelines for reporting these studies.
METHODS: After recognizing the need to have uniform guidelines for reporting of finite element analysis in medicine and dentistry, a group of 5 researchers working on FEA as their research area met in the summer of 2020 and drafted the methodology for the development of such guidelines. Each researcher individually made a list of major headings required for reporting these studies and met again in September 2020 to finalize the domains. Subsequently, sub headings and details were charted. The draft list of items for reporting the guidelines were presented to a larger team of 15 experts and some changes were further made based on their inputs.
RESULTS: The guidelines entail seven major domains and their sub-domains, including parameters for model structure, segmentation, mesh structure, force application and model validation, etc. This checklist aims to improvise the reporting and consistency of FEA studies.
CONCLUSIONS: We hope that the usage and adoption of these guidelines by the scientific community would result in more thoughtful and uniform documentation. Also, the confidence in the results would be enhanced through model reproducibility, reusability and accountability. The proposed guidelines were named as \'Reporting of in-silico studies using finite element analysis in medicine\' and the term \'RIFEM\' was used as acronym.
METHODS: After recognizing the need to have uniform guidelines for reporting of finite element analysis in medicine and dentistry, a group of 5 researchers working on FEA as their research area met in the summer of 2020 and drafted the methodology for the development of such guidelines. Each researcher individually made a list of major headings required for reporting these studies and met again in September 2020 to finalize the domains. Subsequently, sub headings and details were charted. The draft list of items for reporting the guidelines were presented to a larger team of 15 experts and some changes were further made based on their inputs.
RESULTS: The guidelines entail seven major domains and their sub-domains, including parameters for model structure, segmentation, mesh structure, force application and model validation, etc. This checklist aims to improvise the reporting and consistency of FEA studies.
CONCLUSIONS: We hope that the usage and adoption of these guidelines by the scientific community would result in more thoughtful and uniform documentation. Also, the confidence in the results would be enhanced through model reproducibility, reusability and accountability. The proposed guidelines were named as \'Reporting of in-silico studies using finite element analysis in medicine\' and the term \'RIFEM\' was used as acronym.
摘要：
背景：据我们所知，没有设计报告指南，在健康科学中进行和报告有限元研究。我们打算为报告这些研究提出具体和详细的指导方针。
方法：在认识到在医学和牙科中需要有统一的有限元分析报告指南之后，作为研究领域的5名研究人员于2020年夏季开会，起草了制定此类指南的方法。每位研究人员分别列出了报告这些研究所需的主要标题，并于2020年9月再次开会以最终确定该领域。随后，已绘制了子标题和详细信息。报告准则的项目清单草案已提交给一个由15名专家组成的更大的小组，并根据他们的投入进一步进行了一些修改。
结果：该指南涉及七个主要领域及其子领域，包括模型结构的参数，分割，网状结构,力施加和模型验证，等。该清单旨在提高FEA研究的报告和一致性。
结论：我们希望科学界对这些指南的使用和采纳将导致更周到和统一的文档。此外，对结果的信心将通过模型的可重复性得到增强，可重用性和问责制。拟议的指南被命名为“使用医学有限元分析的计算机研究报告”，术语“RIFEM”被用作首字母缩写。
方法：在认识到在医学和牙科中需要有统一的有限元分析报告指南之后，作为研究领域的5名研究人员于2020年夏季开会，起草了制定此类指南的方法。每位研究人员分别列出了报告这些研究所需的主要标题，并于2020年9月再次开会以最终确定该领域。随后，已绘制了子标题和详细信息。报告准则的项目清单草案已提交给一个由15名专家组成的更大的小组，并根据他们的投入进一步进行了一些修改。
结果：该指南涉及七个主要领域及其子领域，包括模型结构的参数，分割，网状结构,力施加和模型验证，等。该清单旨在提高FEA研究的报告和一致性。
结论：我们希望科学界对这些指南的使用和采纳将导致更周到和统一的文档。此外，对结果的信心将通过模型的可重复性得到增强，可重用性和问责制。拟议的指南被命名为“使用医学有限元分析的计算机研究报告”，术语“RIFEM”被用作首字母缩写。
